C-reactive protein and dialysis access

[en] Hemodialysis patients have greater morbidity and mortality when they have a catheter rather than an arteriovenous fistula access. Catheter infection plays a significant role in this effect. Inflammation associated with dialysis catheter use could have an independent adverse effect on patient outcomes. Awareness and further study of the role of inflammation are needed.

Disciplines :

Urology & nephrology

Author, co-author :

Cohen, Eric; Medical College of Wisconsin, Wisconsin, Milwaukee, USA > Nephrology Section

Krzesinski, Jean-Marie ; Université de Liège - ULiège > Département des sciences cliniques > Néphrologie

Language :

English

Title :

C-reactive protein and dialysis access

Publication date :

2009

Journal title :

Kidney International

ISSN :

0085-2538

eISSN :

1523-1755

Publisher :

Nature Publishing Group, New York, United States - New York

Volume :

Pages :

1025-1038

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

http://www.nature.com/ki/journal/v76/n10/abs/ki2009301a.html

Available on ORBi :

since 27 January 2010

Statistics

Number of views

73 (6 by ULiège)

Number of downloads

157 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Goldstein SL, Ikizler TA, Zappitelli M et al. Non-infected hemodialysis catheters are associated with increased inflammation compared to arteriovenous fistulas. Kidney Int 2009; 76: 1063-1069.
Zalokar JB, Richard JL, Claude JR . Leukocyte count, smoking, and myocardial infarction . N Engl J Med 1981; 304: 465-468.
Montecucco M, Mach F. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology 2009; 48: 11-22.
Smith BJ, Lightfoot SA, Lerner MR et al. Induction of cardiovascular pathology in a novel model of low-grade chronic inflammation. Cardiovasc Pathol 2009 18: 1-10
Timpson NJ, Lawler DA, Harbord RM et al. C-reactive protein and its role in metabolic syndrome: mendelian randomization study . Lancet 2005; 366: 1954-1959.
G o A S,C h e rto w G M,F a n D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004 ; 351: 1296-1305.
Kalantar-Zadeh K, Block G, McAllister CJ et al. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients . Am J Clin Nutr 2004; 80: 299-307.
Chiu YL, Chen HY, Chuang YF et al. Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients . Nephrol Dial Transplant 2008; 23: 3685-3689.
Ridker PM, Danielson E, Fonseca FA et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein . N Engl J Med 2008; 359: 2195-2207.
Fellstrom BC, Jardine AG, Schmieder RE et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360: 1455-1457.
Piconi S, Trabattoni D, Luraghi C et al. Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness . F ASEB J 2009 ; 23: 1196-1204.
Mena MP, Sacanella E, Vazquez-Agell M et al. Inhibition of circulating immune cell activation: a molecular antiinflammatory effect of the Mediterranean diet. Am J Clin Nutr 2009 ; 89: 248-256.
Di Guiseppe R, di Castelnuovo A, Centritto F et al. Regular consumption of dark chocolate is associated with low serum concentrations of C-reactive protein in a healthy Italian population . J Nutr 2008; 138: 1939-1945.
Volanakis JE . Human C-reactive protein: expression, structure, and function . Mol Immunol 2001; 38: 189-197.
Yeun JY, Levine RA, Mantadilok V et al. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients . Am J Kidney Dis 2000; 35: 469-476 .